Drugs / wIPV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07457060 | Nov 2025 → Sep 2026 overdue | poliomyelitis | Sinovac Biotech Co., Ltd | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | wIPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07457060 ↗ |
| Modality | Vaccine | “Inactivated Poliovirus Vaccine” NCT07457060 ↗ |
| Route | Intramuscular | “via intramuscular injections” NCT07457060 ↗ |